PIK3CD and urinary bladder carcinoma: Induction of expression of cell surface MHC I and MHC II has previously been shown in head and neck squamous cell carcinomas following PI3K inhibition (51) and in PIK3CA mutant human bladder cancers treated with the PI3K inhibitor BKM120 (52).